Insight Biotechnology search:

<<First <Prev Next> Last>>

Search Results for:
Catalogue No	Partner	Description	Species	Application
HY-N2563-1mg	MedChemexpress LLC	Neocnidilide [CAS 4567-33-3]		COVID-19-immunoregulation
HY-117016-5mg	MedChemexpress LLC	Nonacosadiene [CAS 104410-91-5]
HY-15452-10mg	MedChemexpress LLC	Selisistat [CAS 49843-98-3]		Cancer-programmed cell death
HY-15452-100mg	MedChemexpress LLC	Selisistat [CAS 49843-98-3]		Cancer-programmed cell death
HY-15452-25mg	MedChemexpress LLC	Selisistat [CAS 49843-98-3]		Cancer-programmed cell death
HY-15452-5mg	MedChemexpress LLC	Selisistat [CAS 49843-98-3]		Cancer-programmed cell death
HY-15452-50mg	MedChemexpress LLC	Selisistat [CAS 49843-98-3]		Cancer-programmed cell death
HY-15452-1mL	MedChemexpress LLC	Selisistat [CAS 49843-98-3] (10mM in DMSO)		Cancer-programmed cell death
HY-112820-10mg	MedChemexpress LLC	Chlorantraniliprole [CAS 500008-45-7]
HY-112820-100mg	MedChemexpress LLC	Chlorantraniliprole [CAS 500008-45-7]
HY-112820-25mg	MedChemexpress LLC	Chlorantraniliprole [CAS 500008-45-7]
HY-112820-50mg	MedChemexpress LLC	Chlorantraniliprole [CAS 500008-45-7]
HY-112820-500mg	MedChemexpress LLC	Chlorantraniliprole [CAS 500008-45-7]
HY-112820-1mL	MedChemexpress LLC	Chlorantraniliprole [CAS 500008-45-7] (10mM in DMSO)
HY-139440-100mg	MedChemexpress LLC	DL-Leucyl-DL-phenylalanine [CAS 56217-82-4]
HY-116564-10mg	MedChemexpress LLC	Lotilaner [CAS 1369852-71-0]		COVID-19-immunoregulation
HY-116564-100mg	MedChemexpress LLC	Lotilaner [CAS 1369852-71-0]		COVID-19-immunoregulation
HY-116564-25mg	MedChemexpress LLC	Lotilaner [CAS 1369852-71-0]		COVID-19-immunoregulation
HY-116564-5mg	MedChemexpress LLC	Lotilaner [CAS 1369852-71-0]		COVID-19-immunoregulation
HY-116564-50mg	MedChemexpress LLC	Lotilaner [CAS 1369852-71-0]		COVID-19-immunoregulation
HY-116564-1mL	MedChemexpress LLC	Lotilaner [CAS 1369852-71-0] (10mM in DMSO)		COVID-19-immunoregulation